The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age

• Main Authors: Tianmeng Wen (Author), Xiaoqian Xu (Author), Chenghao Pan (Author), Shangying Hu (Author), Huan Zhao (Author), Xun Zhang (Author), Youlin Qiao (Author), Fanghui Zhao (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The quadrivalent human papillomavirus (qHPV) vaccine demonstrated high efficacy against vaccine-type-related precancers in Chinese females through a 6.6-year double-blind, randomized control trial (V501-041, NCT00834106). We present results for its long-term follow-up (LTFU) phase, evaluating vaccin...